Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam added to sevoflurane for postoperative recovery in elderly laparoscopic surgery patients
ACTRN12626001302347Phase 4Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postoperative recovery comparing Sevoflurane plus remimazolam with Sevoflurane alone (2 arms). Primary endpoint: Quality of early postoperative recovery. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
remimazolamsevoflurane
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on ACTRN12626001302347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626001302347.